Procurement Summary
Country: Japan
Summary: Support Work for "Open-Label, Uncontrolled, Multicenter, Investigator-Initiated Clinical Trial to Confirm the Efficacy and Safety of Repeated Intratumoral Administration of Ad-Sge-Reic-Ns in Patients with Recurrent Glioblastoma"
Deadline: 23 Jul 2026
Posting Date: 08 Jul 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 144748095
Document Ref. No.:
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
Support work for "Open-label, uncontrolled, multicenter, investigator-initiated clinical trial to confirm the efficacy and safety of repeated intratumoral administration of Ad-SGE-REIC-NS in patients with recurrent glioblastoma" Description: Support work for “Open-label, uncontrolled, multicenter, investigator-initiated trial to confirm the efficacy and safety of repeated intratumoral administration of Ad-SGE-REIC-NS in patients with recurrent glioblastoma.” General competitive bidding announcement 1. Procurement details (1) Subject: “... Deadline: 2026-07-23 [Disclaimer: This notice does not specify a specific deadline, so we have added 15 days from the date of posting]
Documents
Tender Notice